Study of IRX4204 With Erlotinib in Previously Treated Advanced NSCLC
Stopped Study drug supply expired. No replacement manufactured. Sponsor did not want to continue study.
Conditions
- Lung Cancer, Nonsmall Cell
Interventions
- DRUG: IRX4204
- DRUG: erlotinib
Sponsor
Io Therapeutics
Collaborators